Literature DB >> 23618608

Improved insight affects social outcomes in involuntarily committed psychotic patients: a longitudinal study in the Netherlands.

Antoon W B van Baars1, André I Wierdsma, Michiel W Hengeveld, Cornelis L Mulder.   

Abstract

BACKGROUND: Lack of insight in schizophrenia is associated with negative social outcomes mediated by symptom severity, but longitudinal studies show contradicting findings.
METHOD: After commencement of court-ordered admission, adult patients were enrolled in a prospective study. A relatively homogeneous group of 133 patients with schizophrenia or related psychotic disorders was selected to evaluate the impact of illness insight and symptom severity on social outcomes. Interviews at baseline and after 6 and 12months included objective and subjective indicators of insight and social outcomes. Multilevel analyses were used to estimate the effect of insight and change in social outcomes controlling for symptom severity.
RESULTS: In 12-month follow-up, patients involuntarily hospitalized showed improvement in illness insight, symptom level, and social functioning, and had stable quality of life scores. Illness insight was associated with change in outcomes, independent from symptom severity. Results of the change analyses suggest that in time the association between insight and functioning becomes stronger. In contrast, insight scores were negatively associated with self-report quality of life ratings and markedly ill patients had a more negative perception of their quality of life.
CONCLUSIONS: Improvement in illness insight was associated with improvement in social functioning, but this was not reflected in improved self-perceived quality of life. Illness insight could result in worrying about relationships, living situation, health and finances. For severely mentally ill patients additional strategies must be found to improve social outcomes. Researchers should be more aware of varying effects for researcher-rated versus self-report indicators of insight and social outcome.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23618608     DOI: 10.1016/j.comppsych.2013.03.016

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  6 in total

1.  Interaction of social role functioning and coping in people with recent-onset attenuated psychotic symptoms: a case study of three Chinese women at clinical high risk for psychosis.

Authors:  TianHong Zhang; HuiJun Li; Kristen A Woodberry; Larry J Seidman; Annabelle Chow; ZePing Xiao; JiJun Wang
Journal:  Neuropsychiatr Dis Treat       Date:  2015-07-06       Impact factor: 2.570

Review 2.  Associations of Quality of Life with Service Satisfaction in Psychotic Patients: A Meta-Analysis.

Authors:  Eleni Petkari; Jakob Pietschnig
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

3.  The assessment of quality of life in clinical practice in patients with schizophrenia.

Authors:  Anne Karow; Linus Wittmann; Daniel Schöttle; Ingo Schäfer; Martin Lambert
Journal:  Dialogues Clin Neurosci       Date:  2014-06       Impact factor: 5.986

4.  Insight as a social identity process in the evolution of psychosocial functioning in the early phase of psychosis.

Authors:  H S Klaas; A Clémence; R Marion-Veyron; J-P Antonietti; L Alameda; P Golay; P Conus
Journal:  Psychol Med       Date:  2016-11-21       Impact factor: 7.723

5.  Insight and Associated Factors among Patients with Schizophrenia in Mental Specialized Hospital, Ethiopia, 2018.

Authors:  Mandaras Tariku; Demeke Demilew; Tolesa Fanta; Meskerem Mekonnen; Dessie Abebaw Angaw
Journal:  Psychiatry J       Date:  2019-11-17

6.  Delusional belief flexibility and informal caregiving relationships in psychosis: a potential cognitive route for the protective effect of social support.

Authors:  S Jolley; H Ferner; P Bebbington; P Garety; G Dunn; D Freeman; D Fowler; E Kuipers
Journal:  Epidemiol Psychiatr Sci       Date:  2013-10-25       Impact factor: 6.892

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.